Terms: = Breast cancer AND MYOD1, ENSG00000129152, 4654, P15172, PUM, MYOD, MYF3 AND Treatment
10 results:
1. Aggressive uveal melanoma displays a high degree of centrosome amplification, opening the door to therapeutic intervention.
Sabat-Pośpiech D; Fabian-Kolpanowicz K; Kalirai H; Kipling N; Coupland SE; Coulson JM; Fielding AB
J Pathol Clin Res; 2022 Jul; 8(4):383-394. PubMed ID: 35474453
[TBL] [Abstract] [Full Text] [Related]
2. Pharmacological Dual Inhibition of Tumor and Tumor-Induced Functional Limitations in a Transgenic Model of breast cancer.
Wang R; Bhat-Nakshatri P; Padua MB; Prasad MS; Anjanappa M; Jacobson M; Finnearty C; Sefcsik V; McElyea K; Redmond R; Sandusky G; Penthala N; Crooks PA; Liu J; Zimmers T; Nakshatri H
Mol Cancer Ther; 2017 Dec; 16(12):2747-2758. PubMed ID: 28978719
[TBL] [Abstract] [Full Text] [Related]
3. Repression of ESR1 transcription by myod potentiates letrozole-resistance in ERα-positive breast cancer cells.
Zhang Q; Liu XY; Li S; Zhao Z; Li J; Cui MK; Wang EH
Biochem Biophys Res Commun; 2017 Oct; 492(3):425-433. PubMed ID: 28842253
[TBL] [Abstract] [Full Text] [Related]
4. UHRF1 inhibits MDR1 gene transcription and sensitizes breast cancer cells to anticancer drugs.
Jin W; Liu Y; Xu SG; Yin WJ; Li JJ; Yang JM; Shao ZM
Breast Cancer Res Treat; 2010 Nov; 124(1):39-48. PubMed ID: 20037778
[TBL] [Abstract] [Full Text] [Related]
5. Estrogen receptor (ER) beta or p53 attenuates ERalpha-mediated transcriptional activation on the BRCA2 promoter.
Jin W; Chen Y; Di GH; Miron P; Hou YF; Gao H; Shao ZM
J Biol Chem; 2008 Oct; 283(44):29671-80. PubMed ID: 18765668
[TBL] [Abstract] [Full Text] [Related]
6. Computed tomography for excision cavity localization and 3D-treatment planning in partial breast irradiation with high-dose-rate interstitial brachytherapy.
Aristei C; Tarducci R; Palumbo I; Cavalli A; Corazzi F; Rulli A; Raymondi C; Latini P
Radiother Oncol; 2009 Jan; 90(1):43-7. PubMed ID: 18037180
[TBL] [Abstract] [Full Text] [Related]
7. The impact of treatment interruptions on locoregional control during postoperative breast irradiation.
Bese NS; Sut PA; Sut N; Ober A
J BUON; 2007; 12(3):353-9. PubMed ID: 17918289
[TBL] [Abstract] [Full Text] [Related]
8. The effect of treatment interruptions in the postoperative irradiation of breast cancer.
Bese NS; Sut PA; Ober A
Oncology; 2005; 69(3):214-23. PubMed ID: 16127290
[TBL] [Abstract] [Full Text] [Related]
9. Bilateral metastatic rhabdomyosarcoma to the breast in an adolescent female: touch imprint cytology and implication of myod1 nuclear antigen.
Tamiolakis D; Venizelos I; Nikolaidou S; Prassopoulos P; Alexiadis G; Simopoulos C; Papadopoulos N
Onkologie; 2004 Oct; 27(5):469-71. PubMed ID: 15585977
[TBL] [Abstract] [Full Text] [Related]
10. breast conservation: long-term results from Westmead Hospital.
Zissiadis Y; Langlands AO; Barraclough B; Boyages J
Aust N Z J Surg; 1997 Jun; 67(6):313-9. PubMed ID: 9193262
[TBL] [Abstract] [Full Text] [Related]
